Munich - Delayed Quote EUR
Ardelyx Inc (41X.MU)
As of 5:26 PM GMT+1. Market Open.
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
28.9
ESG Risk Score for Peers
Name | Total ESG Risk score | E | S | G |
---|---|---|---|---|
GLUE Monte Rosa Therapeutics, Inc. | 29 | -- | -- | -- |
17R.BE TRAVERE THERAP. DL -,0001 | 29 | -- | -- | -- |
41X.MU Ardelyx Inc. R | 29 | -- | -- | -- |
VTYX Ventyx Biosciences, Inc. | 29 | -- | -- | -- |
328.F MeiraGTx Holdings PLC R | 29 | -- | -- | -- |
Controversy Level Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
ESG data provided by Sustainalytics, Inc. Last Updated on 10/2024
41X.MU
Category Average
1 Low Controversy Level
None 4 Severe
1.0 41X.MU
0.4 Category Average
Product Involvement Areas Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
Products and Activities | Significant Involvement |
---|---|
Alcoholic Beverages | No |
Adult Entertainment | No |
Gambling | No |
Tobacco Products | No |
Animal Testing | Yes |
Fur and Specialty Leather | No |
Controversial Weapons | No |
Small Arms | No |
Catholic Values | No |
GMO | No |
Military Contracting | No |
Pesticides | No |
Thermal Coal | No |
Palm Oil | No |
Related Tickers
19KA.SG Cormedix Inc
9.40
0.00%
CZTA.BE Checkpoint Therapeutics Inc
3.1900
+1.75%
LT4.F Liquidia Corporation
9.75
+2.74%
6C1.DU CytomX Therapeutics Inc
0.9255
+0.22%
1JK.F Apellis Pharmaceuticals, Inc.
26.08
-3.39%
BVNKF Bavarian Nordic A/S
28.79
0.00%
1VT.F Viking Therapeutics, Inc.
62.98
+4.69%
XRTX XORTX Therapeutics Inc.
1.5300
+6.25%
LVTX LAVA Therapeutics N.V.
1.8400
-2.65%
SCPH scPharmaceuticals Inc.
4.3550
+0.35%